Browse > Article
http://dx.doi.org/10.22246/jikm.2019.40.4.663

The Effect of Banhasasim-tang in the Treatment of Chemotherapy-induced Symptoms: A Systematic Review  

Ahn, Su-bin (Dept. of Korean Medicine, College of Korean Medicine, Woosuk University)
Lee, Ga-young (Dept. of Korean Medicine, College of Korean Medicine, Woosuk University)
Hwang, Hyeon-ho (Dept. of Korean Medicine, College of Korean Medicine, Woosuk University)
Jeong, Min-jeong (Dept. of Pediatrics, College of Korean Medicine, Woosuk University)
Jang, In-soo (Dept. of Internal Medicine, College of Korean Medicine, Woosuk University)
Publication Information
The Journal of Internal Korean Medicine / v.40, no.4, 2019 , pp. 663-674 More about this Journal
Abstract
Objective: The purpose of this study was to investigate (using a systematic review) the effect of Banhasasim-tang in the treatment of chemotherapy-induced symptoms. Method: A systematic review was conducted to identify the effect of Banhasasim-tang for chemotherapy-induced symptoms. Electronic databases were used, including such as PubMed, Cochrane, CNKI, Wanfang, CiNii, J-STAGE, NDSL, and OASIS. Among others, the main search terms included "cancer", "Banhasasim-tang", "Banxia Xiexin Tang", and "Hangeshashin-to". This study only included randomized controlled trials (RCTs). Results: A total of 14 RCTs were selected. They all identified the effect of Banhasasim-tang in the treatment of chemotherapy-induced symptoms such as nausea, vomiting, and diarrhea. In addition, five of the studies evaluated the preventive effect of Banhasasim-tang on the symptoms. Conclusion: An analysis of 14 RCTs showed that Banhasasim-tang for chemotherapy-induced symptoms might be effective not only for treatment but also for prevention. However, due to the low quality and number of the selected original articles, the significance of this conclusion is somewhat limited. It is hoped that more systematic and rigorous clinical trials will be conducted.
Keywords
cancer; Banhasasim-tang; chemotherapy; systematic review;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Yan L, Zhou J. 40 cases of Banxiaxiexin decoction treating nausea and vomiting by chemotherapy in non-small cell lung cancer. Fujian Journal of TCM 2012;43(2):4-5.
2 Tao F. 20 cases of clinical observation on treating gastric cancer with modified Banxiaxiexin decoction. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine 2013;13(5):40-2.   DOI
3 Ni D. Effect of modified Banxia Xiexin decoction on gastrointestinal response and influence of immune function after gastric cancer operation. Henan Traditional Chinese Medicine 2014;34(6):1013-4.
4 Gu W. Flavored Banxia Xiexin decoction combined with chemotherapy on patients life quality after operation of gastric carcinoma. China Journal of Chinese Medicine 2015;30(204):626-8.
5 Zhang R, Li Y. Study on clinical effect of Banxiaxiexin decoction pungent-opening and bitter-descending method in treating colon cancer. Lab Med Clin 2017;14(19):2904-8.
6 Sun Z. Clinical study of treating colon cancer with Banxiaxiexin decoction with pungent-opening and bitter-descending method. Asia-Pacific Traditional Medicine 2017;13(8):125-6.
7 Fan L. Therapeutic effect of Banxia Xiexin decoction as adjuvant therapy on colon cancer. Contemporary Medical Symposium 2018;16(13):147-8.
8 Wang L, Mu L. Clinical observation on treating gastric cancer at stage III-IV with combined therapy of Chinese and western medicine. Western Journal of Traditional Chinese Medicine 2018;31(11):93-5.
9 Wang J, Yin Y, Li X, Ma Z, Ma J, Zhi Z, et al. Clinical study of Banxia Xiexin decoction combined with mFOLFOX6 chemotherapy in the treatment of advanced colon cancer. Information on Traditional Chinese Medicine 2019;36(1):34-7.
10 He J. Observation of gastrointenstinal toxicity by chemotherapy with Banxiaxiexin decoction. Journal of Emergency in Traditional Chinese Medicine 2010;19(4):581-2.   DOI
11 Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy:prevention and treatment. Clin Pharmacol Ther 2011;90(3):377-87.   DOI
12 Yamazaki K, Ariyoshi N, Miyauchi H, Ohira G, Kaneya N, Yamamoto K, et al. A randomized controlled, open-label early phase II trial comparing incidence of FOLFIRI.3-induced diarrhoea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer. J Clin Pharm Ther 2019 Aug 13. doi:10.1111/jcpt.13020.
13 Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006;33(1):15-49.   DOI
14 Postma TJ, Heimans JJ. Grading of chemotherapy induced peripheral neuropathy. Ann Oncol 2000;11(5):509-13.   DOI
15 Choi JY, Cho JH, Bae GE, Shim SH, Seo HJ, Choi JY, et al. A case report of a patient with chemotherapy-induced leukopenia treated with acupuncture. J Internal Korean Med 2017;28(5):806-11.
16 Cho NK, Lee YR, Choi HS, Kim KS, Kim SM. A case report of chemotherapy-induced stomatitis clinically improved by acupuncture treatment. J Korean Traditional Oncol 2017;22(2):25-31.   DOI
17 Jeon SY, Kim WB, Seok EJ, Song SY, Jeong JG, Lee SI. An analysis of clinical studies on Banha-sasim-tang. Herbal Formula Science 2018;26(3):267-81.   DOI
18 Kim HS, Choi JE, Yoo HS. The effectiveness of gargling Hwangryunhaedok-tang on chemotherapy-induced stomatitis. J Korean Traditional Oncol 2011;16(1):1-14.   DOI
19 Kim MS, Jung YJ, Hong SH. Clinical effectiveness of traditional herbal medicine in the treatment of chemotherapy-induced leukopenia: a systematic review and meta-analysis of randomized clinical trials. J Internal Korean Med 2018;39(4):520-49.   DOI
20 Kook YB, Kim SC, Park SD, Park SK, Seo BI, Seo YB, et al. Herbal formula study. Seoul: Younglimsa; 2006, p. 162-4.
21 DeVita VT Jr, Chu E. A History of Cancer Chemotherapy. Cancer Res 2008;68(21):8643-53. doi: 10.1158/0008-5472.CAN-07-6611.   DOI
22 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018 Nov;68(6):394-424. doi:10.3322/caac.21492.   DOI
23 Riley L, Cowan M, Abernethie A, Mozes R, Sheffer K. Noncommunicable diseases country profiles 2018. Geneva: World Health Organization;2018, Available at https://www.who.int/nmh/publications/ncd-profiles-2018/en/ [Accessed: Aug 22 2019]
24 Kim J, Kim R. Cause of death statistics 2017. Statistics Korea. Available at http://www.kostat.go.kr/portal/korea/kor_nw/1/6/2/index.board?bmode=read&bSeq=&aSeq=370710&pageNo=1&rowNum=10&navCount=10&currPg=&searchInfo=&sTarget=title&sTxt=[Accessed: Aug 22 2019]
25 Choi DY, Kim JK, Shang HL. interpretation. Seoul: Dae Sung book; 1995, p. 228-30.
26 Lim S, Yi M. Study on cancer patients who visited an emergency department with the side effects of chemotherapy. J Korean Clin Nurs Res 2014;20(1):75-89.   DOI
27 Gilmore J, D'Amato S, Griffith N, Schwartzberg L. Recent advances in antiemetics: new formulations of $5HT_3$-receptor antagonists. Cancer Manag Res 2018 Jul 3;10:1827-57. doi: 10.2147/CMAR.S166912.   DOI
28 Moon J, Ahn G, Kim S, Park J, Kim D, Choi D, et al. Shanghanlun Jeonghae. Seoul: Haneui Munhwasa; 2010, p. 317-9.
29 Lee S. Shingobangchancha. Seoul: Koonja; 2012, p. 267-8.
30 Jeon SY, Kim WB, Seok EJ, Song SY, Jeong JG. An analysis of clinical studies on Banha-Sasim-Tang. Herbal Formula Science 2018;26(3):267-81.   DOI
31 Kim SY, Park JE, Seo HJ, Lee YJ, Jang BH, Suh HS, et al. NECA's guidance for undertaking systematic reviews and meta-analyses for intervention. 1st ed. Seoul: National Evidence-based Healthcare Collaborating Agency; 2011, p. 65-92.
32 Mori K, Kondo T, Kamiyama Y, Kano Y, Tominaga K. Preventive effect of Kampo medicine(Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 2003;51(5):403-6.   DOI
33 Yu Y, Zhang L, Cai Q, Xu Y. Revised Pinellia combination threat digestive tract reaction from chemical therapy after operation of gastric cancer. Journal of Zhejiang University of Traditional Chinese Medicine 2006;30(4):401-2.   DOI
34 Wang L. 40 case series : combination of Chinese and western medicine to prevent gastrointestinal reaction caused by chemotherapy. Jiangxi Journal of Traditional Chinese Medicine 2010;41(329):42-3.